Susquehanna Portfolio Strategies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2M Buy
612,127
+86,550
+16% +$5.77M 0.66% 32
2026
Q1
$33M Sell
525,577
-1,915
-0.4% -$133K 0.49% 51
2025
Q4
$35M Buy
+527,492
New +$34.1M 0.54% 38
2025
Q3
Sell
-11,543
Closed -$1.01M 1056
2025
Q2
$1.01M Buy
+11,543
New +$905K 0.02% 504

Other funds holding DXCM

Susquehanna Portfolio Strategies's DXCM Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $5.77M and bringing the position to 612,127 shares worth $41.2M. The position accounts for 0.66% of the portfolio, ranked #32.

Susquehanna Portfolio Strategies first reported a position in DXCM in Q2 2025 and has held it in 4 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Susquehanna Portfolio Strategies held 612,127 shares of DexCom worth $41.2M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 86,550 DexCom shares in Q2 2026, an estimated $5.77M.
  • DexCom made up 0.66% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #32 holding.
  • Susquehanna Portfolio Strategies first reported a position in DexCom in Q2 2025 and has held it in 4 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.